Obesity isn’t straightforward. In 50 years, obesity rates have tripled – and they’re still going up. Has there really been a global loss of willpower or is there something more complex going on? To tackle all the complex issues out there, it'll take some out-there answers. Now is the time to do things differently. #NovoNordisk #DrivingChange #Obesity?
诺和诺德
制药业
Get updates around our progress and challenges to champion long-term health ?? #DrivingChange
关于我们
Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat serious chronic diseases, built upon our heritage in diabetes. We do so by pioneering scientific breakthroughs, expanding access to our medicines, and working to prevent and ultimately cure disease. Novo Nordisk employs about 66,000 people in 80 countries and markets its products in around 170 countries. For more information visit novonordisk.com. This page isn’t intended for discussions about products. As such, postings or comments that contain product discussions may be removed. This page is for discussions about Novo Nordisk and its subsidiaries and the initiatives and projects we are involved in. While we welcome everyone to make comments, we reserve the right to remove those that are off-topic, abusive or intended to spam. Any questions specific to products should be made to your healthcare professional. If you wish to file an adverse drug reaction please contact Novo Nordisk’s office in the country you live in: https://www.novonordisk.com/contact-us/find-local-information.html For other customer complaints, please contact us here: https://www.novonordisk.com/contact-us.html Please keep in mind that Novo Nordisk A/S and its subsidiaries work within a highly regulated industry. Therefore, comments that pertain to legal matters or regulatory issues may be removed. Comments contained on this site come from members of the public, and do not necessarily reflect the views of Novo Nordisk A/S. Novo Nordisk A/S does not endorse or approve any content added by other LinkedIn users. Learn more about our privacy disclaimer and community guidelines here: https://www.novonordisk.com/data-privacy-and-user-rights/social-media-privacy-disclaimer.html
- 网站
-
https://www.novonordisk.com
诺和诺德的外部链接
- 所属行业
- 制药业
- 规模
- 超过 10,001 人
- 总部
- Bagsv?rd
- 类型
- 上市公司
- 创立
- 1923
- 领域
- Pharmaceuticals、Insulin、obesity、Rare Diseases和Diabetes
地点
诺和诺德员工
-
Thomas R?ygaard
PMO | Digital Transformation | Leading Program, Project and Portfolio Management | Governance | Change Management
-
Naras Eechambadi
Board Director | Executive Coach | C-Suite Executive | Global Leader in Data, Analytics & AI | Ex - McKinsey
-
S?ren Meelby
Digital Healthcare Evangelist | Cultivating Partnerships for Collective Impact & Social Good
-
Henrik Vestergaard
动态
-
Women are driving change every day—across research, production, and beyond. This #InternationalWomensDay, we’re celebrating those who #AccelerateAction for a healthier future. From the science behind producing life-saving medicines to fostering mentorship, these women and their allies are shaping long-term health solutions for generations to come. Who inspires you to take action? Tag them below ?? #DrivingChange #IWD2025?
-
Is obesity really a disease? Let’s explore three factors that contribute to obesity. We're committed to driving change in obesity and promoting long-term health. One way to do this is to create a deeper understanding of the topic. ? #NovoNordisk #DrivingChange #WorldObesityDay?
-
Imagine someone you care for has a rare bleeding disorder that affects only 1 in 5 million people. This #RareDiseaseDay, we’re highlighting a story from our colleagues Ronja and Jackie ?????? 3 years ago, their daughter, Elizabeth, was diagnosed with factor 13 deficiency. Today, with the right treatment and care, Elizabeth is living like any other child her age. Inspired by their journey the family wants to make a difference for others living with rare diseases. Learn more about rare diseases here: https://lnkd.in/epaPnsgB #NovoNordisk #DrivingChange
-
Over the last five years, the number of patients we are helping has increased by nearly 50%. This has created a need to build more factories - but are there ways to do this with less environmental impact????? Come with us to our new factory site in Odense, Denmark. Here, Laila and her colleagues take some novel approaches to?preserving nature and biodiversity ?? #NovoNordisk #DrivingChange #Sustainability??
-
How do we create value for society? ??? ? Learn more about our commitment to people living with serious chronic diseases, innovation, and access to healthcare in our #AnnualReport 2024.?? ?? Experience the interactive report first-hand or download the PDF here: https://lnkd.in/dxSA_D4V
-
This International Day of Women and Girls in Science, let’s talk about why it’s important to have more women working in the field. Meet Alice Carter-Jones, our epidemiology specialist who works with big data every day to improve treatments for people living with chronic diseases. Beyond her work, she’s involved in the organisations we partner with like Women in Data?, helping to create a future where more women lead in STEM. Are you interested in pursuing your career with us? Learn about our many career paths here: https://lnkd.in/dXYGZc58? #DrivingChange #WomenInScience #STEM
-
That’s a wrap for our annual Graduate Recruitment Centre where we had the pleasure of assessing 304 talented candidates from over 50 nationalities as part of the recruitment process for the next batch of graduates ?? ? Over the past three days, these young innovators showcased their skills and teamwork while tackling a challenging business case. This event was the highlight of several months of campaigning, screening and interviews with candidates eager to join us.? ? The overwhelming interest and the quality of the applicants in our Graduate Programme underscores the importance of our approach to attracting the right talent with an interest in driving change in long-term health globally ?? ? Do you want to learn more about our Graduate Programme? Click ?? ?https://lnkd.in/d3Nc2whD And don't forget to sign up for the Global Talent Hub ?? #novonordisk
-
-
Our full-year results for 2024 are out! ?? Our CEO Lars Fruergaard J?rgensen breaks down some of the key highlights, including how we scaled our global production and reached more than 45 million people with our medicines.? ?? A big thanks to the more than 77,000 colleagues around the world for the dedication in bringing innovative medicine to people living with serious chronic diseases.? ?? Read more about our achievements and ambitions in our Annual Report 2024 ?? https://lnkd.in/gu4MH2U ? #NovoNordisk #DrivingChange #FullYearResults
-
We have just been ranked among the top 50 all-stars in Fortune's World's Most Admired Companies – and as the second most admired pharmaceutical company. These recognitions reflect our dedication to improving lives through innovation and our commitment to corporate responsibility. ? If you also want to make a difference and help shape the future of health, you can explore career opportunities here: https://lnkd.in/dfHdaYP #MostAdmiredCompanies
-